Why are clinical trials struggling with diversity?
pharmaphorum
MAY 26, 2022
Within pharma and healthcare, where greater representation has been proven to lead to better health outcomes for all patients and the pharmaceutical companies developing medicines, change is also happening. As a Non-Clinical Assessor at MHRA he assessed non-clinical data packages for new and generic medicines.
143 
Let's personalize your content